| Product NDC: | 63739-459 |
| Proprietary Name: | Procainamide Hydrochloride |
| Non Proprietary Name: | Procainamide Hydrochloride |
| Active Ingredient(s): | 100 mg/mL & nbsp; Procainamide Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63739-459 |
| Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089069 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100201 |
| Package NDC: | 63739-459-05 |
| Package Description: | 5 BAG in 1 BOX (63739-459-05) > 1 VIAL, MULTI-DOSE in 1 BAG > 10 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 63739-459-05 |
| Proprietary Name | Procainamide Hydrochloride |
| Package Description | 5 BAG in 1 BOX (63739-459-05) > 1 VIAL, MULTI-DOSE in 1 BAG > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 63739-459 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Procainamide Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100201 |
| Marketing Category Name | ANDA |
| Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
| Substance Name | PROCAINAMIDE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |